Cartesian Therapeutics, Inc. Other Comprehensive Income (Loss), Net of Tax
Cartesian Therapeutics, Inc. (RNAC) reported Other Comprehensive Income (Loss), Net of Tax of -$137.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-15.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2019-03-15
- Cartesian Therapeutics, Inc. other comprehensive income (loss), net of tax for the quarter ending 2018-12-31 was -$40.00K.
- Cartesian Therapeutics, Inc. other comprehensive income (loss), net of tax for the quarter ending 2018-09-30 was -$41.00K.
- Cartesian Therapeutics, Inc. other comprehensive income (loss), net of tax for the quarter ending 2018-06-30 was -$78.00K.
- Cartesian Therapeutics, Inc. other comprehensive income (loss), net of tax for the quarter ending 2018-03-31 was $22.00K, a 84.06% decline year-over-year.
- Cartesian Therapeutics, Inc. other comprehensive income (loss), net of tax for fiscal 2018 was -$137.00K.
- Cartesian Therapeutics, Inc. other comprehensive income (loss), net of tax for fiscal 2016 was $468.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$81.00K derived: sum of 2 quarters · filed 2019-03-15 | -$159.00K derived: sum of 3 quarters · filed 2019-03-15 | -$137.00K 10-K · filed 2019-03-15 |
| 2018-09-30 | -$41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$119.00K derived: sum of 2 quarters · filed 2018-11-08 | -$97.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$56.00K 10-Q · filed 2018-08-08 | ||
| 2018-03-31 | $22.00K 10-Q · filed 2018-05-09 | |||
| 2017-03-31 | $138.00K 10-Q · filed 2017-05-11 | |||
| 2016-12-31 | $468.00K 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |